CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (Nasdaq: IDRA) today announced that Sudhir Agrawal, D.Phil., Chairman and Chief Executive Officer, is scheduled to present at the UBS 2011 Global Life Sciences Conference in New York City on Wednesday, September 21st at 7:30 am ET. Dr. Agrawal will provide a review of Idera’s updated corporate strategy, including its plans with respect to its Toll-like Receptor-targeted development programs and its gene silencing oligonucleotide (GSO) technology.
